Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$64.81T
24h Vol:
$5.92B
Dominance:
MSFT:4.76%
Stocklytics Platform
Asset logo  COO
Cooper Cos
COO
57 / 100
S&P500
$97.23arrow_drop_down0.68%-$0.67

Performance History

Stocklytics logo
Key Stats
Open$98.15
Prev. Close$97.90
EPS1.46
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$18.83B
PE Ratio67.37
LOWHIGH
Day Range97.83
98.44
52 Week Range75.93
104.07
Ratios
P/B Ratio2.42
Revenue$3.59B
Operating M. %16.43%
Earnings$294.20M
Earnings Growth %-23.74%
EBITDA Margin %24.57%
ROE %3.87%
EPS1.46

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$776.94
24H (%)arrow_drop_down1.28%
24H ($)-$10.08
MARKET CAP$722.30B
PRICE$523.34
24H (%)arrow_drop_up1.11%
24H ($)$5.79
MARKET CAP$471.98B
PRICE$153.39
24H (%)arrow_drop_up0.47%
24H ($)$0.72
MARKET CAP$360.78B
PRICE$131.12
24H (%)arrow_drop_down0.46%
24H ($)-$0.61
MARKET CAP$329.41B

About Cooper Cos (COO)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Albert G. White III
Headquarters
San Ramon
Employees
14000
Exchange
NYSE
add Cooper Cos to watchlist

Keep an eye on Cooper Cos

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Cooper Cos's (COO) price per share?

The current price per share for Cooper Cos (COO) is $98.36. The stock has seen a price change of $0.46 recently, indicating a 0.47% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Cooper Cos (COO)?

For Cooper Cos (COO), the 52-week high is $104.07, which is 5.81% from the current price. The 52-week low is $75.94, the current price is 29.53% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Cooper Cos (COO) a growth stock?

Cooper Cos (COO) has shown an average price growth of 0.41% over the past three years. It has received a score of 20 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cooper Cos as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Cooper Cos (COO) stock price performance year to date (YTD)?

As of the latest data, Cooper Cos (COO) has a year-to-date price change of 5.46%. Over the past month, the stock has experienced a price change of 6.87%. Over the last three months, the change has been 5.04%. Over the past six months, the figure is 15.21%. Looking at a longer horizon, the five-year price change stands at 35.31%.

help
Is Cooper Cos (COO) a profitable company?

Cooper Cos (COO) has a net income of $294.2M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 65.62% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 16.43% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $3.59B, with a revenue growth rate of 8.61%, providing insight into the company's sales performance and growth. The gross profit is $2.36B. Operating income is noted at $533.1M. Furthermore, the EBITDA is $903.9M.

help
What is the market capitalization of Cooper Cos (COO)?

Cooper Cos (COO) has a market capitalization of $18.83B. The average daily trading volume is 788.48K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level